Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
AHA comments on the Centers for Medicare & Medicaid Services’ calendar year 2019 proposed rule for the Home Health prospective payment system.
AHA comments on the Drug Enforcement Administration’s (DEA) notice of proposed rulemaking on aggregate production quotas for Schedule I and II controlled substances.
AHA letter to the US Senate supporting Amendment #3787 to address ‘out-of-control cost’ of prescription drugs.
RE: CMS-1720-NC, Request for Information Regarding the Physician Self-referral Law
dl iconDownload the letter (PDF)
AHA shares Value-Based Care recommendations with Congressional Caucus.
AHA comments on the Centers for Medicare & Medicaid Services' agency information collection notice on the home health “Review Choice” demonstration.
AHA letter to the Senate expressing support for Robert Wilkie Department.of Veteran Affairs Nomination.
AHA expresses disappointment that the Agency for Healthcare Research and Quality is shutting down the National Guidelines Clearinghouse.
AHA, health organizations letter to CMS regarding its decision to suspend billions of dollars in annual payments to insurers as required under the Affordable Care Act’s risk-adjustment program.
AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.